Loading…

FKBP12.6 mice display temporal gender differences in cardiac Ca super(2+)-signalling phenotype upon chronic pressure overload

Preventing Ca super(2+)-leak during diastole may provide a means to improve overall cardiac function. The immunosuppressant FK506-binding protein 12.6 (FKBP12.6) regulates ryanodine receptor-2 (RyR2) gating and binds to and inhibits calcineurin (Cn). It is also involved in the pathophysiology of hea...

Full description

Saved in:
Bibliographic Details
Published in:Canadian journal of physiology and pharmacology 2011-11, Vol.89 (11), p.769-782
Main Authors: Previlon, Miresta, Pezet, Mylene, Semprez, Fannie, Mercadier, Jean-Jacques, Rouet-Benzineb, Patricia
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 782
container_issue 11
container_start_page 769
container_title Canadian journal of physiology and pharmacology
container_volume 89
creator Previlon, Miresta
Pezet, Mylene
Semprez, Fannie
Mercadier, Jean-Jacques
Rouet-Benzineb, Patricia
description Preventing Ca super(2+)-leak during diastole may provide a means to improve overall cardiac function. The immunosuppressant FK506-binding protein 12.6 (FKBP12.6) regulates ryanodine receptor-2 (RyR2) gating and binds to and inhibits calcineurin (Cn). It is also involved in the pathophysiology of heart failure (HF). Here, we investigated the effects of FKBP12.6 over-expression and gender on Ca super(2+)-handling proteins (RyR2, SERCA2a/PLB, and NCX), and on pro-(CaMKII, Cn/NFAT) and anti-hypertrophic (GSK3 beta ) signalling pathways in a thoracic aortic constriction (TAC) mouse model. Wild type mice (WT) and mice over-expressing FKBP12.6 of both genders underwent TAC or sham-operation (Sham). FKBP12.6 over-expression ameliorated post-TAC survival rates in both genders. Over time, FKBP12.6 over-expression reduced the molecular signature of left ventricular hypertrophy (LVH) and the transition to HF (BNP and beta -MHC mRNAs) and attenuated Cn/NFAT activation in TAC-males only. The gender difference in pro- and anti-hypertrophic LVH signals was time-dependent: TAC-females exhibited earlier pathological LVH associated with concomitant SERCA2a down-regulation, CaMKII activation, and GSK3 beta inactivation. Both genotypes showed systolic dysfunction, possibly related to down-regulated RyR2, but only FK-TAC-males exhibited preserved diastolic LV function. Although FKBP12.6 over-expression did not impact the vicious cycle of TAC-induced HF, this study reveals some subtle sequential and temporal gender differences in Ca super(2+)-signalling pathways of pathological LVH.Original Abstract: Prevenir la fuite du Ca super(2+) au cours de la diastole pourrait s'averer une strategie d'amelioration de la fonction cardiaque globale. La proteine FKBP12,6 controle l'ouverture des recepteurs 2 de la ryanodine (RyR2) et inhibe la calcineurine (Cn). Elle est aussi impliquee dans la pathophysiologie de l'insuffisance cardiaque (HF). Dans cette etude, on analyse les effets de la surexpression de FKBP12,6 et du genre sur les proteines de l'homeostasie calcique (RyR2, SERCA2a/PLB et NCX) et sur les voies de signalisation pro-(CaMKII, Cn/NFAT) et anti-hypertrophiques (GSK3 beta ) dans un modele (souris) d'hypertrophie cardiaque induite par la constriction de l'aorte thoracique (TAC). On soumet les souris surexprimant la FKBP12,6 et des souris de type sauvage (WT) des deux sexes a une operation TAC ou a une operation simulee (Sham). La surexpression de FKBP12,6 ameliore le taux de surv
doi_str_mv 10.1139/y11-075
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1562672139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1562672139</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_15626721393</originalsourceid><addsrcrecordid>eNqVj81KxDAURoMoWH_wFe5yRDIm6fTHrYOD4MaF-yGkt51ImsR7W6EL390ufAFXH-dwNp8Qd1pttS6fHhetpWqqM1FooyrZVDt9LgqlVCt3RptLccX8uWLdlm0hfg5vz-_abGsYvUPoPOdgF5hwzIlsgAFjh7T6vkfC6JDBR3CWOm8d7C3wnJE25uFesh-iDcHHAfIJY5qWjDDntOYnStE7yITMMyGkb6SQbHcjLnobGG__9lpsDi8f-1eZKX3NyNNx9OwwBBsxzXzUVW3qxqw3y3-kvzvgV0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1562672139</pqid></control><display><type>article</type><title>FKBP12.6 mice display temporal gender differences in cardiac Ca super(2+)-signalling phenotype upon chronic pressure overload</title><source>SPORTDiscus with Full Text (EBSCO)</source><creator>Previlon, Miresta ; Pezet, Mylene ; Semprez, Fannie ; Mercadier, Jean-Jacques ; Rouet-Benzineb, Patricia</creator><creatorcontrib>Previlon, Miresta ; Pezet, Mylene ; Semprez, Fannie ; Mercadier, Jean-Jacques ; Rouet-Benzineb, Patricia</creatorcontrib><description>Preventing Ca super(2+)-leak during diastole may provide a means to improve overall cardiac function. The immunosuppressant FK506-binding protein 12.6 (FKBP12.6) regulates ryanodine receptor-2 (RyR2) gating and binds to and inhibits calcineurin (Cn). It is also involved in the pathophysiology of heart failure (HF). Here, we investigated the effects of FKBP12.6 over-expression and gender on Ca super(2+)-handling proteins (RyR2, SERCA2a/PLB, and NCX), and on pro-(CaMKII, Cn/NFAT) and anti-hypertrophic (GSK3 beta ) signalling pathways in a thoracic aortic constriction (TAC) mouse model. Wild type mice (WT) and mice over-expressing FKBP12.6 of both genders underwent TAC or sham-operation (Sham). FKBP12.6 over-expression ameliorated post-TAC survival rates in both genders. Over time, FKBP12.6 over-expression reduced the molecular signature of left ventricular hypertrophy (LVH) and the transition to HF (BNP and beta -MHC mRNAs) and attenuated Cn/NFAT activation in TAC-males only. The gender difference in pro- and anti-hypertrophic LVH signals was time-dependent: TAC-females exhibited earlier pathological LVH associated with concomitant SERCA2a down-regulation, CaMKII activation, and GSK3 beta inactivation. Both genotypes showed systolic dysfunction, possibly related to down-regulated RyR2, but only FK-TAC-males exhibited preserved diastolic LV function. Although FKBP12.6 over-expression did not impact the vicious cycle of TAC-induced HF, this study reveals some subtle sequential and temporal gender differences in Ca super(2+)-signalling pathways of pathological LVH.Original Abstract: Prevenir la fuite du Ca super(2+) au cours de la diastole pourrait s'averer une strategie d'amelioration de la fonction cardiaque globale. La proteine FKBP12,6 controle l'ouverture des recepteurs 2 de la ryanodine (RyR2) et inhibe la calcineurine (Cn). Elle est aussi impliquee dans la pathophysiologie de l'insuffisance cardiaque (HF). Dans cette etude, on analyse les effets de la surexpression de FKBP12,6 et du genre sur les proteines de l'homeostasie calcique (RyR2, SERCA2a/PLB et NCX) et sur les voies de signalisation pro-(CaMKII, Cn/NFAT) et anti-hypertrophiques (GSK3 beta ) dans un modele (souris) d'hypertrophie cardiaque induite par la constriction de l'aorte thoracique (TAC). On soumet les souris surexprimant la FKBP12,6 et des souris de type sauvage (WT) des deux sexes a une operation TAC ou a une operation simulee (Sham). La surexpression de FKBP12,6 ameliore le taux de survie post-TAC des souris des deux sexes. Avec le temps, la surexpression de FKBP12,6 attenue la signature moleculaire de l'hypertrophie du ventricule gauche (LVH) et la progression vers HF (BNP et beta -ARNm CMH) et attenue aussi l'activation de Cn/NFAT seulement chez les souris males TAC. La difference de signalisation pro- et anti-hypertrophique entre les deux genres se manifeste dans le temps : les femelles TAC presentent une LVH pathologique plus precoce associee simultanement a la regulation et a la baisse de SERCA2a, a l'activation de CaMKII et a l'inactivation de GSK3 beta . Les deux genotypes presentent une dysfonction systolique probablement associee a la regulation et a la baisse de RyR2, mais seulement les males FK TAC preservent la fonction diastolique du ventricule gauche. Meme si la surexpression de FKBP12,6 ne brise pas le cercle vicieux de l'HF suscitee par la TAC, cette etude revele de subtiles differences entre les deux genres en ce qui concerne la sequence et la chronologie des voies de signalisation du Ca super(2+) en presence de LVH pathologique.</description><identifier>ISSN: 0008-4212</identifier><identifier>EISSN: 1205-7541</identifier><identifier>DOI: 10.1139/y11-075</identifier><language>eng</language><ispartof>Canadian journal of physiology and pharmacology, 2011-11, Vol.89 (11), p.769-782</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Previlon, Miresta</creatorcontrib><creatorcontrib>Pezet, Mylene</creatorcontrib><creatorcontrib>Semprez, Fannie</creatorcontrib><creatorcontrib>Mercadier, Jean-Jacques</creatorcontrib><creatorcontrib>Rouet-Benzineb, Patricia</creatorcontrib><title>FKBP12.6 mice display temporal gender differences in cardiac Ca super(2+)-signalling phenotype upon chronic pressure overload</title><title>Canadian journal of physiology and pharmacology</title><description>Preventing Ca super(2+)-leak during diastole may provide a means to improve overall cardiac function. The immunosuppressant FK506-binding protein 12.6 (FKBP12.6) regulates ryanodine receptor-2 (RyR2) gating and binds to and inhibits calcineurin (Cn). It is also involved in the pathophysiology of heart failure (HF). Here, we investigated the effects of FKBP12.6 over-expression and gender on Ca super(2+)-handling proteins (RyR2, SERCA2a/PLB, and NCX), and on pro-(CaMKII, Cn/NFAT) and anti-hypertrophic (GSK3 beta ) signalling pathways in a thoracic aortic constriction (TAC) mouse model. Wild type mice (WT) and mice over-expressing FKBP12.6 of both genders underwent TAC or sham-operation (Sham). FKBP12.6 over-expression ameliorated post-TAC survival rates in both genders. Over time, FKBP12.6 over-expression reduced the molecular signature of left ventricular hypertrophy (LVH) and the transition to HF (BNP and beta -MHC mRNAs) and attenuated Cn/NFAT activation in TAC-males only. The gender difference in pro- and anti-hypertrophic LVH signals was time-dependent: TAC-females exhibited earlier pathological LVH associated with concomitant SERCA2a down-regulation, CaMKII activation, and GSK3 beta inactivation. Both genotypes showed systolic dysfunction, possibly related to down-regulated RyR2, but only FK-TAC-males exhibited preserved diastolic LV function. Although FKBP12.6 over-expression did not impact the vicious cycle of TAC-induced HF, this study reveals some subtle sequential and temporal gender differences in Ca super(2+)-signalling pathways of pathological LVH.Original Abstract: Prevenir la fuite du Ca super(2+) au cours de la diastole pourrait s'averer une strategie d'amelioration de la fonction cardiaque globale. La proteine FKBP12,6 controle l'ouverture des recepteurs 2 de la ryanodine (RyR2) et inhibe la calcineurine (Cn). Elle est aussi impliquee dans la pathophysiologie de l'insuffisance cardiaque (HF). Dans cette etude, on analyse les effets de la surexpression de FKBP12,6 et du genre sur les proteines de l'homeostasie calcique (RyR2, SERCA2a/PLB et NCX) et sur les voies de signalisation pro-(CaMKII, Cn/NFAT) et anti-hypertrophiques (GSK3 beta ) dans un modele (souris) d'hypertrophie cardiaque induite par la constriction de l'aorte thoracique (TAC). On soumet les souris surexprimant la FKBP12,6 et des souris de type sauvage (WT) des deux sexes a une operation TAC ou a une operation simulee (Sham). La surexpression de FKBP12,6 ameliore le taux de survie post-TAC des souris des deux sexes. Avec le temps, la surexpression de FKBP12,6 attenue la signature moleculaire de l'hypertrophie du ventricule gauche (LVH) et la progression vers HF (BNP et beta -ARNm CMH) et attenue aussi l'activation de Cn/NFAT seulement chez les souris males TAC. La difference de signalisation pro- et anti-hypertrophique entre les deux genres se manifeste dans le temps : les femelles TAC presentent une LVH pathologique plus precoce associee simultanement a la regulation et a la baisse de SERCA2a, a l'activation de CaMKII et a l'inactivation de GSK3 beta . Les deux genotypes presentent une dysfonction systolique probablement associee a la regulation et a la baisse de RyR2, mais seulement les males FK TAC preservent la fonction diastolique du ventricule gauche. Meme si la surexpression de FKBP12,6 ne brise pas le cercle vicieux de l'HF suscitee par la TAC, cette etude revele de subtiles differences entre les deux genres en ce qui concerne la sequence et la chronologie des voies de signalisation du Ca super(2+) en presence de LVH pathologique.</description><issn>0008-4212</issn><issn>1205-7541</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqVj81KxDAURoMoWH_wFe5yRDIm6fTHrYOD4MaF-yGkt51ImsR7W6EL390ufAFXH-dwNp8Qd1pttS6fHhetpWqqM1FooyrZVDt9LgqlVCt3RptLccX8uWLdlm0hfg5vz-_abGsYvUPoPOdgF5hwzIlsgAFjh7T6vkfC6JDBR3CWOm8d7C3wnJE25uFesh-iDcHHAfIJY5qWjDDntOYnStE7yITMMyGkb6SQbHcjLnobGG__9lpsDi8f-1eZKX3NyNNx9OwwBBsxzXzUVW3qxqw3y3-kvzvgV0A</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Previlon, Miresta</creator><creator>Pezet, Mylene</creator><creator>Semprez, Fannie</creator><creator>Mercadier, Jean-Jacques</creator><creator>Rouet-Benzineb, Patricia</creator><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20111101</creationdate><title>FKBP12.6 mice display temporal gender differences in cardiac Ca super(2+)-signalling phenotype upon chronic pressure overload</title><author>Previlon, Miresta ; Pezet, Mylene ; Semprez, Fannie ; Mercadier, Jean-Jacques ; Rouet-Benzineb, Patricia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_15626721393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Previlon, Miresta</creatorcontrib><creatorcontrib>Pezet, Mylene</creatorcontrib><creatorcontrib>Semprez, Fannie</creatorcontrib><creatorcontrib>Mercadier, Jean-Jacques</creatorcontrib><creatorcontrib>Rouet-Benzineb, Patricia</creatorcontrib><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Canadian journal of physiology and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Previlon, Miresta</au><au>Pezet, Mylene</au><au>Semprez, Fannie</au><au>Mercadier, Jean-Jacques</au><au>Rouet-Benzineb, Patricia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FKBP12.6 mice display temporal gender differences in cardiac Ca super(2+)-signalling phenotype upon chronic pressure overload</atitle><jtitle>Canadian journal of physiology and pharmacology</jtitle><date>2011-11-01</date><risdate>2011</risdate><volume>89</volume><issue>11</issue><spage>769</spage><epage>782</epage><pages>769-782</pages><issn>0008-4212</issn><eissn>1205-7541</eissn><abstract>Preventing Ca super(2+)-leak during diastole may provide a means to improve overall cardiac function. The immunosuppressant FK506-binding protein 12.6 (FKBP12.6) regulates ryanodine receptor-2 (RyR2) gating and binds to and inhibits calcineurin (Cn). It is also involved in the pathophysiology of heart failure (HF). Here, we investigated the effects of FKBP12.6 over-expression and gender on Ca super(2+)-handling proteins (RyR2, SERCA2a/PLB, and NCX), and on pro-(CaMKII, Cn/NFAT) and anti-hypertrophic (GSK3 beta ) signalling pathways in a thoracic aortic constriction (TAC) mouse model. Wild type mice (WT) and mice over-expressing FKBP12.6 of both genders underwent TAC or sham-operation (Sham). FKBP12.6 over-expression ameliorated post-TAC survival rates in both genders. Over time, FKBP12.6 over-expression reduced the molecular signature of left ventricular hypertrophy (LVH) and the transition to HF (BNP and beta -MHC mRNAs) and attenuated Cn/NFAT activation in TAC-males only. The gender difference in pro- and anti-hypertrophic LVH signals was time-dependent: TAC-females exhibited earlier pathological LVH associated with concomitant SERCA2a down-regulation, CaMKII activation, and GSK3 beta inactivation. Both genotypes showed systolic dysfunction, possibly related to down-regulated RyR2, but only FK-TAC-males exhibited preserved diastolic LV function. Although FKBP12.6 over-expression did not impact the vicious cycle of TAC-induced HF, this study reveals some subtle sequential and temporal gender differences in Ca super(2+)-signalling pathways of pathological LVH.Original Abstract: Prevenir la fuite du Ca super(2+) au cours de la diastole pourrait s'averer une strategie d'amelioration de la fonction cardiaque globale. La proteine FKBP12,6 controle l'ouverture des recepteurs 2 de la ryanodine (RyR2) et inhibe la calcineurine (Cn). Elle est aussi impliquee dans la pathophysiologie de l'insuffisance cardiaque (HF). Dans cette etude, on analyse les effets de la surexpression de FKBP12,6 et du genre sur les proteines de l'homeostasie calcique (RyR2, SERCA2a/PLB et NCX) et sur les voies de signalisation pro-(CaMKII, Cn/NFAT) et anti-hypertrophiques (GSK3 beta ) dans un modele (souris) d'hypertrophie cardiaque induite par la constriction de l'aorte thoracique (TAC). On soumet les souris surexprimant la FKBP12,6 et des souris de type sauvage (WT) des deux sexes a une operation TAC ou a une operation simulee (Sham). La surexpression de FKBP12,6 ameliore le taux de survie post-TAC des souris des deux sexes. Avec le temps, la surexpression de FKBP12,6 attenue la signature moleculaire de l'hypertrophie du ventricule gauche (LVH) et la progression vers HF (BNP et beta -ARNm CMH) et attenue aussi l'activation de Cn/NFAT seulement chez les souris males TAC. La difference de signalisation pro- et anti-hypertrophique entre les deux genres se manifeste dans le temps : les femelles TAC presentent une LVH pathologique plus precoce associee simultanement a la regulation et a la baisse de SERCA2a, a l'activation de CaMKII et a l'inactivation de GSK3 beta . Les deux genotypes presentent une dysfonction systolique probablement associee a la regulation et a la baisse de RyR2, mais seulement les males FK TAC preservent la fonction diastolique du ventricule gauche. Meme si la surexpression de FKBP12,6 ne brise pas le cercle vicieux de l'HF suscitee par la TAC, cette etude revele de subtiles differences entre les deux genres en ce qui concerne la sequence et la chronologie des voies de signalisation du Ca super(2+) en presence de LVH pathologique.</abstract><doi>10.1139/y11-075</doi></addata></record>
fulltext fulltext
identifier ISSN: 0008-4212
ispartof Canadian journal of physiology and pharmacology, 2011-11, Vol.89 (11), p.769-782
issn 0008-4212
1205-7541
language eng
recordid cdi_proquest_miscellaneous_1562672139
source SPORTDiscus with Full Text (EBSCO)
title FKBP12.6 mice display temporal gender differences in cardiac Ca super(2+)-signalling phenotype upon chronic pressure overload
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T06%3A09%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FKBP12.6%20mice%20display%20temporal%20gender%20differences%20in%20cardiac%20Ca%20super(2+)-signalling%20phenotype%20upon%20chronic%20pressure%20overload&rft.jtitle=Canadian%20journal%20of%20physiology%20and%20pharmacology&rft.au=Previlon,%20Miresta&rft.date=2011-11-01&rft.volume=89&rft.issue=11&rft.spage=769&rft.epage=782&rft.pages=769-782&rft.issn=0008-4212&rft.eissn=1205-7541&rft_id=info:doi/10.1139/y11-075&rft_dat=%3Cproquest%3E1562672139%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_miscellaneous_15626721393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1562672139&rft_id=info:pmid/&rfr_iscdi=true